Michiel-de-Bruin, Co-Founder
Odesso Health’s Clinical Data Connector Launches On the athenahealth Marketplace and Appian AI Marketplace
02 nov. 2023 08h00 HE | Odesso Health
Odesso Health’s newest solution Clinical Data Connector, uses AI and machine learning to extract clinical data to automate EMR/EHR workflows and protect healthcare providers in electronic medical...
Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics Completes Clinical Enrollment of First Cohort and Updates on Long-lasting Impact in First Patients Treated in Ongoing Phase I/II Trial of NRTX-1001 Cell Therapy for Drug-resistant Focal Epilepsy
19 oct. 2023 08h00 HE | Neurona Therapeutics
First cohort treated in Ph I/II clinical trial of NRTX-1001 in adults with focal epilepsy, update on first patients'progress
enteralogo.png
Entera Bio Reports Rapid Pharmacodynamic (PD) Response and Consistent Pharmacokinetic (PK) Data for its First-in-Class Oral PTH(1-34) Mini Tablets at the ASBMR 2023 Annual Meeting
16 oct. 2023 08h00 HE | Entera Bio Ltd.
JERUSALEM, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, presented...
h1-logo-main (1).png
H1 Launches H1 Mobile App to Empower Medical Affairs with Real-Time KOL Insights and Expertise on the Go
14 août 2023 09h00 HE | H1
NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global HCP, clinical, scientific, and research information, today announced the release of the iOS mobile app, H1...
MNPR Triangle 2.JPG
Monopar Provides Encouraging Camsirubicin Clinical Data Update
08 août 2023 07h00 HE | Monopar Therapeutics Inc.
WILMETTE, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for...
biosig_rgb.png
New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias
19 mai 2023 07h30 HE | BioSig Technologies, Inc.
Data from three abstracts highlight the potential of an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI) Preservation of raw unipolar signal using BioSig’s...
Arbutus Biopharma Logo
Arbutus Provides AB-729 Clinical Data and AB-161 Preclinical Data as Oral Presentations at the Global Hepatitis Summit 2023
27 avr. 2023 03h20 HE | Arbutus Biopharma Corporation
Seven patients with cHBV remain off all treatment and continue to maintain low levels of HBV DNA and HBsAg for at least one and half years post- AB-729 treatment AB-161 provides robust anti-HBV...
Logo_Horizontal_Fill_White_Transparent.png
Neurona Therapeutics Presents Updated Data from the NRTX-1001 Cell Therapy Trial in Adults with Drug-resistant Focal Epilepsy at American Academy of Neurology (AAN) 2023 Annual Meeting
24 avr. 2023 08h00 HE | Neurona Therapeutics
NRTX-1001 administration is well-tolerated with continued seizure reduction of >90% in the first two patients at nine- and five-months post-treatment, respectively Impaired-awareness seizures...
MDG_LOGO_2016_GRAY_RGB.jpg
Medigene AG presents final Phase I data of TCR-T cell therapy MDG1011 in patients with high-risk blood cancers
24 avr. 2023 05h00 HE | Medigene AG
MDG1011 was generally well tolerated in nine heavily pre-treated patients across three ascending dose levelsNo neurotoxicity or dose-limiting toxicities observedTwo out of nine patients showed early...
h1-logo-main (1).png
H1.co Named 2023 Website of the Year by the Health And IT Marketing Community
18 avr. 2023 09h00 HE | H1
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- H1, the connecting force for global healthcare provider, clinical, science, and research information, is proud to announce that it has been awarded the...